Nilotinib is marketed under the trade name Tasigna. It is a a small-molecule tyrosine kinase inhibitor used as a possible treatment for chronic myelogenous leukemia (CML).
Cancer Research and Antivirals
|Appearance||off white solid|
Send us your enquiry for Nilotinib. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Nilotinib email us and we will include your contribution on the website.